A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis

NCT07158151 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis of Adults

Interventions

DRUG: RSS0393 ointment
DRUG: RSS0393 ointment
DRUG: RSS0393 ointment
DRUG: RSS0393 ointment

Sponsor

Reistone Biopharma Company Limited